Crossmark

The lung-protective effect of prior mRNA vaccination on breakthrough COVID-19 patients receiving high flow nasal oxygen for hypoxemic acute respiratory failure

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2022.07.003

Published Online: 2025-03-10

Published Print: 2023-09-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Giraudo, C.

Guarnieri, G. https://orcid.org/0000-0003-3664-2024
Molena, B.

Caminati, M.

Stramare, R. https://orcid.org/0000-0002-1818-2290
Vianello, A. https://orcid.org/0000-0002-8790-6029
License Information

Version of Record valid from 2023-09-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2022-05-23

Accepted: 2022-07-04

Published: 2025-03-10

Document is current

Any future updates will be listed below